BeOne Medicines (BEIGF) Shares Outstanding (Diluted) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.23 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 208.22 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 45.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 115.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 115.80 Mn |
| Mar 31, 2026 | 115.77 Mn |
| Dec 31, 2025 | 113.45 Mn |
| Sep 30, 2025 | 114.52 Mn |
| Jun 30, 2025 | 112.56 Mn |
| Mar 31, 2025 | 111.17 Mn |
| Dec 31, 2024 | 105.29 Mn |
| Sep 30, 2024 | 105.90 Mn |
| Jun 30, 2024 | 104.70 Mn |
| Mar 31, 2024 | 104.27 Mn |
| Dec 31, 2023 | 104.39 Mn |
| Sep 30, 2023 | 106.95 Mn |
| Jun 30, 2023 | 104.63 Mn |
| Mar 31, 2023 | 104.17 Mn |
| Dec 31, 2022 | 103.13 Mn |
| Sep 30, 2022 | 103.48 Mn |
| Jun 30, 2022 | 102.80 Mn |
| Mar 31, 2022 | 102.46 Mn |
| Dec 31, 2021 | 92.79 Mn |
| Sep 30, 2021 | 92.77 Mn |